Karolina Mrugała
Research Subjects
Karolina Mrugała has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Anna Szpernalowska
Warsaw Southern Hospital Rotmistrza Witolda Pileckiego 99, 02-781 Warsaw
3 shared publications - Jakub Kalisiak
Independent Public Complex of Health Care Facilities of the Ministry of Interior and Administration in Poznan, Dojazd Str. 34, 60-631 Poznan, Poland
3 shared publications - Martyna Choinka
University Clinical Hospital in Poznan, Przybyszewskiego Str. 49, 60-355 Poznan, Poland
3 shared publications - Vimbisoyashe Ivy Matshaba
University Clinical Hospital in Poznan, Długa 1/2, 61-848 Poznan, Poland
3 shared publications - Anna Mataczyńska
Lazarski University, Faculty of Medicine
2 shared publications - Michał Paprocki
Lazarski University, Faculty of Medicine
2 shared publications
Latest Publications
- Open Access
- 25 October 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 28, 55360
Development of Hashimoto's disease in patients with vitiligo
The aim of this paper is to review the available scientific literature on the relationship between vitiligo and the development of Hashimoto's disease, with particular emphasis on possible pathogenetic mechanisms and clinical implications of this correlation. The relationship between vitiligo and thyroid diseases, especially Hashimoto's disease, has intrigued researchers for years. Numerous clinical observations suggested that patients with vitiligo more often struggle with thyroid problems, but only extensive epidemiological studies allowed for a precise estimate of the scale of this phenomenon.
- 25 October 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 28, 55360
Open AccessDevelopment of Hashimoto's disease in patients with vitiligo
The aim of this paper is to review the available scientific literature on the relationship between vitiligo and the development of Hashimoto's disease, with particular emphasis on possible pathogenetic mechanisms and clinical implications of this correlation. The relationship between vitiligo and thyroid diseases, especially Hashimoto's disease, has intrigued researchers for years. Numerous clinical observations suggested that patients with vitiligo more often struggle with thyroid problems, but only extensive epidemiological studies allowed for a precise estimate of the scale of this phenomenon.
- Open Access
- 29 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 23, 55368
Human Immunodeficiency Virus - a Review of the clinical aspects and detection of the infection
Introduction: Currently, many people are infected with the human immunodeficiency virus (HIV). Transmission is primarily through sexual contact, with additional routes including mother-infant exposure to needles and needle sharing. Since the HIV/AIDS pandemic was first identified in 1981, more than 75 million people have been infected. Numerous new cases continue to be reported, and infection can become the starting point for the development of HIV. Clinical manifestations include acute retroviral syndrome, opportunistic infections, and dermatological, neuromuscular, and other complications. Despite advances in antiretroviral therapy (ART), challenges remain, including drug resistance, opportunistic infections, and persistent HIV reservoirs in some cell types. Early and accurate diagnosis is essential, and recommended testing protocols include fourth-generation serological tests and point-of-care (POC) testing. ART, which includes combinations of antiretroviral drugs, is the standard treatment, and ongoing research into gene therapy shows promise for the future. Purpose of the work: The aim of this study is to review and characterize the clinical aspects and detection of human immunodeficiency virus infection. Materials and methods: A comprehensive analysis of research papers available on PubMed, Google Scholar, Web of Science, Embase and Scopus was undertaken using the searchterms encompassing the following keywords: HIV, human immunodeficiency virus, ART, HIV manifestation, HIV detection, HIV diagnosis, HIV treatment.
- 29 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 23, 55368
Open AccessHuman Immunodeficiency Virus - a Review of the clinical aspects and detection of the infection
Introduction: Currently, many people are infected with the human immunodeficiency virus (HIV). Transmission is primarily through sexual contact, with additional routes including mother-infant exposure to needles and needle sharing. Since the HIV/AIDS pandemic was first identified in 1981, more than 75 million people have been infected. Numerous new cases continue to be reported, and infection can become the starting point for the development of HIV. Clinical manifestations include acute retroviral syndrome, opportunistic infections, and dermatological, neuromuscular, and other complications. Despite advances in antiretroviral therapy (ART), challenges remain, including drug resistance, opportunistic infections, and persistent HIV reservoirs in some cell types. Early and accurate diagnosis is essential, and recommended testing protocols include fourth-generation serological tests and point-of-care (POC) testing. ART, which includes combinations of antiretroviral drugs, is the standard treatment, and ongoing research into gene therapy shows promise for the future. Purpose of the work: The aim of this study is to review and characterize the clinical aspects and detection of human immunodeficiency virus infection. Materials and methods: A comprehensive analysis of research papers available on PubMed, Google Scholar, Web of Science, Embase and Scopus was undertaken using the searchterms encompassing the following keywords: HIV, human immunodeficiency virus, ART, HIV manifestation, HIV detection, HIV diagnosis, HIV treatment.
- Open Access
- 24 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 22, 54744
Autism Spectrum Disorder: Latest Advances in Treatment
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition marked by deficits in social communication and the presence of restricted, repetitive behaviours. Despite the global prevalence of ASD, its diagnosis and treatment remain challenging due to the absence of specific biomarkers and the heterogeneity of symptoms. ASD is incurable and current management options aim to minimize the symptoms and maximize the patients’ ability to function. There is no one standardized treatment for ASD at present, recommended medical interventions involve various therapies which include cognitive behavioral therapy alongside additional personalized pharmacological symptomatic treatments. New approach for ASD management includes sensory integration therapy (SIT) as well as dietary interventions, like gluten-free, casein-free and ketogenic diets. Other innovative treatment strategies are targeted at gut microbiome and include probiotic treatment and fecal microbiota transplant. In this review possible genetic variants associated with ASD are discussed as well as their influence on the manifestation and management of clinical symptoms. For a better understanding on how genetic variables impact drug effectiveness in individuals and the importance of pharmacogenetics in ASD. This paper aims to explore the available and possible treatment options as well the genetic components associated with ASD. In summary, this paper reviews the current and emerging treatment options for ASD.
- 24 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 22, 54744
Open AccessAutism Spectrum Disorder: Latest Advances in Treatment
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition marked by deficits in social communication and the presence of restricted, repetitive behaviours. Despite the global prevalence of ASD, its diagnosis and treatment remain challenging due to the absence of specific biomarkers and the heterogeneity of symptoms. ASD is incurable and current management options aim to minimize the symptoms and maximize the patients’ ability to function. There is no one standardized treatment for ASD at present, recommended medical interventions involve various therapies which include cognitive behavioral therapy alongside additional personalized pharmacological symptomatic treatments. New approach for ASD management includes sensory integration therapy (SIT) as well as dietary interventions, like gluten-free, casein-free and ketogenic diets. Other innovative treatment strategies are targeted at gut microbiome and include probiotic treatment and fecal microbiota transplant. In this review possible genetic variants associated with ASD are discussed as well as their influence on the manifestation and management of clinical symptoms. For a better understanding on how genetic variables impact drug effectiveness in individuals and the importance of pharmacogenetics in ASD. This paper aims to explore the available and possible treatment options as well the genetic components associated with ASD. In summary, this paper reviews the current and emerging treatment options for ASD.